BRAF Targets in Melanoma: Biological Mechanisms, Resistance, and Drug Discovery: 82 (Cancer Drug Discovery and Development, 82) - Image 1

£75.80

Humana BRAF Targets in Melanoma: Biological Mechanisms, Resistance, and Drug Discovery: 82 (Cancer Drug Discovery and Development, 82)

Name: BRAF Targets in Melanoma: Biological Mechanisms, Resistance, and Drug Discovery: 82 (Cancer Drug Discovery and Development, 82)
Brand: Humana
Price: 75.8 GBP
Availability: InStock

General Medical Issues

This is the most expensive it has ever been. Walk away.

£76 today · previous high £76 · all-time low £28

NEW HERE?

Amazon shows you one price. We show you all of them.

Tosheroon watches Amazon prices so you don't have to. Every product on Amazon has a price history — we make it visible. Set the price you'd actually pay, and we'll email you the second it gets there. No app, no account, one email.

WHAT'S ON THIS PAGE

↓ Price chart
when this has been cheap or pricey

↓ Forecast
where the price is heading next

↓ Statistics
all-time high & low, recent range

↑ Price alert
name your number, we'll email you

Price History & Forecast

Grey patches = out of stock. Cheaper = lower on the chart. Hover for exact prices.

Last 631 days • 631 data points (No recent data available)

Historical

Generating forecast...

Price Distribution

Price distribution over 631 days • 8 price levels

Days at Price

Current Price

Price Analysis

Most common price: £75 (189 days, 30.0%)

Price range: £28 - £76

Price levels: 8 different prices over 631 days

Description

This volume contains a collection of writings from the leaders in the fields of Molecular Biology and Melanoma Research which will begin to tell the ever-expanding story of the most recent findings, discoveries, and potential of BRAF-directed targets in melanoma. Recent research has shown that BRAF inhibitors are effective for a short period of time, but there is little hope that this drugs as single agents will lead to durable benefit in a majority of patients. Among scientists and researchers who work in drug discovery, there is a lot of interest in the development of molecularly targeted cancer agents. Namely, the identification of a molecular target, the selection of molecules which effectively inhibit this target. What is starkly different about the development of this class of compounds, however, is that the mechanism of action of these agents are not as straightforward as was once previously assumed and the mechanisms of resistance that tumor cells employ to evade complete destruction are unlike any that have been described before. These discoveries in addition to utilization of modern molecular biology techniques have led to a series of hypotheses regarding which other types of molecules could be used in combination with BRAF-inhibitors in hopes of revolutionizing the potential of therapeutics in melanoma.

Product Specifications

Brand: Humana
Format: hardcover
ASIN: 1493921428
Category: Books > Subjects > Health, Family & Lifestyle > Medical & Healthcare Practitioners > General Medical Issues
Domain: Amazon UK
Release Date: 25 November 2014
Listed Since: 22 August 2014

Barcode

No barcode data available

Humana BRAF Targets in Melanoma: Biological Mechanisms, Resistance, and Drug Discovery: 82 (Cancer Drug Discovery and Development, 82)

This is the most expensive it has ever been. Walk away.

Price History & Forecast

Price Distribution

Price Analysis

Description

Product Specifications

Barcode

Similar Products You Might Like

Molecular Diagnostics for Melanoma: Methods and Protocols: 1102 (Methods in Molecular Biology, 1102)

New Therapies in Advanced Cutaneous Malignancies

Diagnostic and Prognostic Biomarkers and Therapeutic Targets in Melanoma (Current Clinical Pathology)

Human Melanoma: From Basic Research to Clinical Application

Melanoma: 167 (Cancer Treatment and Research, 167)

Melanoma: A Modern Multidisciplinary Approach

Somatic alterations in critical genes in malignant melanoma: Effect on global gene expression

Targeted Therapeutics in Melanoma (Current Clinical Oncology)

MELANOMA MOLECULAR BIOLOGY: Molecular Biology, Risk Factors & Treatment Options (Cancer Etiology, Diagnosis and Treatments: Dermatology - Laboratory and Clincal Research)

Melanoma: Translational Research and Emerging Therapies: 8 (Translational Medicine)

Non-melanoma Skin Cancer: Essentials for Oncologists (Series in Medical Physics and Biomedical Engineering)

The Intersection of Dermatology and Oncology, An Issue of Dermatologic Clinics (Volume 37-4) (The Clinics: Dermatology, Volume 37-4)

WHO Classification of Skin Tumours: WHO Classification of Tumours, Volume 11 (World Health Organization classification of tumours)

Cutaneous Melanoma, Fifth Edition

Melanoma, An Issue of Hematology/Oncology Clinics of North America: Volume 35-1 (The Clinics: Internal Medicine, Volume 35-1)

Genetics of Melanoma (Cancer Genetics)

Oncodermatology: An Evidence-Based, Multidisciplinary Approach to Best Practices

Current Research and Clinical Management of Melanoma: 65 (Cancer Treatment and Research, 65)

Melanoma, An Issue of Clinics in Plastic Surgery (Volume 48-4) (The Clinics: Surgery, Volume 48-4)

Cutaneous Oncology, An Issue of Hematology/Oncology Clinics of North America (Volume 38-5) (The Clinics: Internal Medicine, Volume 38-5)

The Moss Report - Skin Cancer: MelanomaTreatment Guide

Melanoma Development: Molecular Biology, Genetics and Clinical Application

Immunotherapy of Melanoma

Skin Cancer (Site-specific Cancer Series)